Regulation of insulin-like growth factor-I in starvation and injury

Nutrition Reviews

Volumn 57, Issue 6, 1999, Pages 167-176

  Thissen, Jean Paul ^a   Underwood, Louis E ^b   Ketelslegers, Jean Marie ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLUCOCORTICOID; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; INSULIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

CALORIC INTAKE; CATABOLISM; CRITICAL ILLNESS; DIET RESTRICTION; GENE EXPRESSION REGULATION; GROWTH DISORDER; GROWTH HORMONE RELEASE; HORMONE RESISTANCE; HYPOTHALAMUS; INSULIN BLOOD LEVEL; MALNUTRITION; NUTRITION; PROTEIN INTAKE; REGULATORY MECHANISM; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; STARVATION;

EID: 0032786770     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.1999.tb06939.x     Document Type: Review

References (53)

1. Souba WW. Nutritional support. N Engl J Med 1997; 336:41-8
2. Clemmons DR, Klibanski A, Underwood LE, et al. Reduction of plasma immunoreactive somatomedin-C during fasting in humans. J Clin Endocrinol Metab 1981;53:1247-50
3. Dahn MS, Lange MP, Jacobs LA. Insulin-like growth factor-I production is inhibited in human sepsis. Arch Surg 1988;123:1409-14
4. Mauras N, Beaufrere B. Recombinant human IGF-I enhances whole body protein anabolism and significantly diminishes the protein catabolic effect of prednisone in humans without a diabetogenic effect. J Clin Endocrinol Metab 1995;80:869-74
5. Daughaday WH, Rotwein P. Insulin-like growth factors I and II: peptide, messenger ribonucleic acid, and gene structures, serum, and tissue concentrations. Endocrinol Rev 1989;10:68-91
6. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrinol Rev 1995;16:3-34
7. Clemmons DR, Underwood LE, Dickerson RN, et al. Use of plasma somatomedin-C/insulin-like growth factor-I measurements to monitor the response to nutritional repletion in malnourished patients. Am J Clin Nutr 1985;41:191-8
8. Isley WL, Underwood LE, Clemmons DR. Dietary components that regulate serum somatomedin-C concentrations in humans. J Clin Invest 1983;71: 175-82
9. Clemmons DR, Seek MM, Underwood LE. Supplemental essential amino acids augment the somatomedin-C/insulin-like growth factor-I response to refeeding after fasting. Metabolism 1985;34:391-5
10. Tannenbaum GS, Rorstad O, Brazeau P. Effects of prolonged food deprivation on the ultradian growth hormone rhythm and immunoreactive somatostatin tissue levels in the rat. Endocrinology 1979;104: 1733-8
11. Tannenbaum GS, Epelbaum J, Colle E, et al. Antiserum to somatostatin reverses starvation-induced inhibition of growth hormone but not insulin secretion. Endocrinology 1978;102:1909-14
12. Bruno JF, Song J, Berelowitz M. Regulation of rat hypothalamic preprogrowth hormone-releasing factor messenger ribonucleic acid by dietary protein. Endocrinology 1991;129:1226-32
13. Vuagnat BAM, Pierroz DD, Lalaoui M, et al. Evidence for a leptin-neuropeptide Y axis for the regulation of growth hormone secretion in the rat. Neuroendocrinology 1998;67:291-300
14. Maes M, Underwood LE, Ketelslegers JM. Plasma somatomedin-C in fasted and refed rats: close relationship with changes in liver somatogenic but not lactogenic binding sites. J Endocrinol 1983;97: 243-52
15. Maiter D, Maes M, Underwood LE, et al. Early changes in serum concentrations of somatomedin-C induced by dietary protein deprivation in rats: contributions of growth hormone receptor and postreceptor defects. J Endocrinol 1988;118:113-20
16. Thissen JP, Triest S, Underwood LE, et al. Divergent responses of serum insulin-like growth factor-I and liver growth hormone (GH) receptors to exogenous GH in protein-restricted rats. Endocrinology 1990;126:908-13
17. Ninh NX, Maiter D, Lause P, et al. Continuous administration of growth hormone (GH) does not prevent the decrease of IGF-I gene expression in zinc-deprived rats despite normalization of liver GH binding. Growth Regul 1997;7:1-8
18. Mulumba N, Massa G, Ketelslegers JM, Maes M. Ontogeny and nutritional regulation of the serum growth hormone binding protein in the rat. Acta Endocrinol (Copenhagen) 1991;125:409-15
19. Boni-Schnetzler M, Schmid C, Meier PJ, Froesch ER. Insulin regulates insulin-like growth factor-I mRNA in rat hepatocytes. Am J Physiol 1991;260: E846-51
20. Maiter D, Fliesen T, Underwood LE, et al. Dietary protein restriction decreases insulin-like growth factor-I independent of insulin and liver growth hormone binding. Endocrinology 1989;124:2604-11
21. Thissen JP, Pucilowska J, Underwood LE. Differential regulation of IGF-I and IGFBP-1 mRNAs by amino acid availability and growth hormone in rat hepatocyte primary culture. Endocrinology 1994; 134:1570-6
22. Jousse C, Bruhat A, Ferrara M, Fafournoux P. Physiological concentration of amino acids regulates insulin-like growth-factor-binding protein 1 expression. Biochem J 1998;334:147-53
23. Pao CI, Farmer PK, Begovic S, et al. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein-1 gene transcription by hormones and amino acids in rat hepatocytes. Mol Endocrinol 1993;7:1561-8
24. Lefebvre D, Beckers F, Ketelslegers JM, Thissen JP. Zinc regulation of insulin-like growth factor-I (IGF-I), growth hormone receptor (GHR), and binding protein (GHBP) gene expression in rat cultured hepatocytes. Mol Cell Endocrinol 1998;138:127-36
25. Emler CA, Schalch DS. Nutritionally induced changes in hepatic insulin-like growth factor-I (IGF-I) gene expression in rats. Endocrinology 1987; 120:832-4
26. Straus DS, Takemoto CD. Effect of fasting on insulin-like growth factor-I and growth hormone receptor mRNA levels and IGF-I gene transcription in rat liver. Mol Endocrinol 1990;4:91-100
27. Zhang JH, Chrysis D, Underwood LE. Reduction of hepatic insulin-like growth factor I (IGF-I) messenger ribonucleic acid (mRNA) during fasting is associated with diminished splicing of IGF-I pre-mRNA and decreased stability of cytoplasmic IGF-I mRNA. Endocrinology 1998;139:4523-30
28. Thissen JP, Triest S, Moats-Staats BM, et al. Evidence that pretranslational and translational defects decrease serum IGF-I concentrations during dietary protein restriction. Endocrinology 1991;129: 429-35
29. Zhang JH, Whitehead Jr RE, Underwood LE. Effect of fasting on insulin-like growth factor (IGF)-IA and IGF-IB messenger ribonucleic acids and prehormones in rat liver. Endocrinology 1997;138: 3112-8
30. Thissen JP, Underwood LE. Translational status of the insulin-like growth factor-I mRNA in liver of protein-restricted rats. J Endocrinol 1992;132:141-7
31. 125I]-labeled IGF-I in protein-restricted rats. Am J Physiol 1992;262:E406-11
32. Thissen JP, Underwood LE, Maiter D, et al. Failure of IGF-I infusion to promote growth in protein-restricted rats despite normalization of serum IGF-I concentrations. Endocrinology 1991;128:885-90
33. Ninh NX, Maiter D, Verniers J, et al. Failure of exogenous IGF-I to restore normal growth in rats submitted to dietary zinc deprivation. J Endocrinol 1998;159:211-7
34. Lefebvre D, Boney CM, Ketelslegers JM, Thissen JP. Inhibition of the insulin-like growth factor (IGF)-I mitogenic action by zinc chelation is associated with decreased mitogen-activated protein kinase (MAPK) activation in rat-1 fibroblasts. FEBS Lett 1999;449:284-8
35. Timmins AC, Cotterill AM, Hughes SCC, et al. Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth-factor-binding protein-3 protease. Crit Care Med 1996;24:1460-6
36. Davenport ML, Isley WL, Pucilowska JB, et al. Insulin-like growth-factor-binding protein-3 proteolytic activity is induced following elective surgery. J Clin Endocrinol Metab 1992;75:590-5
37. Ross R, Miell J, Freeman E, et al. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I. Clin Endocrinol 1991;35:47-54
38. Van den Berghe G, De Zegher F, Veldhuis JD, et al. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. J Clin Endocrinol Metab 1997;82:590-9
39. Reisen JN, McDonnell KJ, Mulroney SE, Lumpkin MD. Endotoxin-induced suppression of the somatotropic axis is mediated by interleukin-1ß and corticotrophin-releasing factor in the juvenile rat. Endocrinology 1995;136:3378-90
40. Liao W, Rudling M, Angelin B. Contrasting effects of growth hormone and insulin-like growth factor-I on the biological activities of endotoxin in the rat. Endocrinology 1997;138:289-95
41. Van den Berghe G, De Zegher F, Bouillon R. Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998;83:1827-34
42. Defalque D, Brandt N, Ketelslegers JM, Thissen JP. Growth hormone insensitivity induced by endotoxin injection is associated with decreased GH receptors. Am J Physiol 1999;276:E565-72
43. Fan J, Char D, Bagby GJ, et al. Regulation of insulin-like growth factor-I (IGF-I) and IGF binding proteins by tumor necrosis factor. Am J Physiol 1995;269:R1204-12
44. Lang CH, Fan J, Cooney R, Vary TC. IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis. Am J Physiol 1996;270:E430-7
45. Thissen JP, Verniers J. Inhibition by interleukin-1ß and tumor necrosis factor-α of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture. Endocrinology 1997;138:1078-84
46. Beauloye V, Ketelslegers JM, Moreau B, Thissen JP. Dexamethasone inhibits both growth hormone (GH)-induction of insulin-like growth factor-1 (IGF-1) mRNA and GH receptor (GHR) mRNA levels in rat primary cultured hepatocytes. Growth Hormone and IGF Research, in press
47. Fan J, Wojnar M, Theodorakis M, Lang CH. Regulation of insulin-like growth factor (IGF)-I mRNA and peptide and IGF-binding proteins by interleukin-1. Am J Physiol 1996;270:R621-9
48. Fan J, Char D, Kolasa AJ, et al. Alterations in hepatic production and peripheral clearance of IGF-I after endotoxin. Am J Physiol 1995;269:E33-42
49. Frost RA, Lang CH, Gelato MC. Transient exposure of human myoblasts to tumor necrosis factor-inhibits serum and insulin-like growth factor-I stimulated protein synthesis. Endocrinology 1997;138: 4153-9
50. Bird JLE, Tyler JA. Tumour necrosis factor α, interferon γ and dexamethasone regulate IGF-I-maintained collagen production in cultured human fibroblasts. J Endocrinol 1995;147:167-76
51. Jurasinski CV, Vary TC. Insulin-like growth factor I accelerates protein synthesis in skeletal muscle during sepsis. Am J Physiol 1995;269:E977-81
52. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocrinol Rev 1994;15:80-101
53. Thissen JP, Maiter D, Underwood LE, Ketelslegers JM. Nutrition et axe somatotrope: des mécanismes moléculaires à la clinique. Médecine/Sciences 1995;11:1225-33